Rod D Martin - Net Worth and Insider Trading

Rod D Martin Net Worth

The estimated net worth of Rod D Martin is at least $28 Million dollars as of 2024-11-10. Rod D Martin is the Director of Galectin Therapeutics Inc and owns about 9,448,910 shares of Galectin Therapeutics Inc (GALT) stock worth over $28 Million. Details can be seen in Rod D Martin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rod D Martin has not made any transactions after 2014-01-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Rod D Martin

To

Rod D Martin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rod D Martin owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .

Click here to see the complete history of Rod D Martin’s form 4 insider trades.

Insider Ownership Summary of Rod D Martin

Ticker Comapny Transaction Date Type of Owner
GALT Galectin Therapeutics Inc 2014-01-13 director

Rod D Martin Latest Holdings Summary

Rod D Martin currently owns a total of 1 stock. Rod D Martin owns 9,448,910 shares of Galectin Therapeutics Inc (GALT) as of January 13, 2014, with a value of $28 Million.

Latest Holdings of Rod D Martin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GALT Galectin Therapeutics Inc 2014-01-13 9,448,910 3.00 28,346,730

Holding Weightings of Rod D Martin


Rod D Martin Form 4 Trading Tracker

According to the SEC Form 4 filings, Rod D Martin has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the sale of 100,000 shares on January 13, 2014, which brought Rod D Martin around $1 Million.

Insider Trading History of Rod D Martin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rod D Martin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Rod D Martin Ownership Network

Ownership Network List of Rod D Martin

No Data

Ownership Network Relation of Rod D Martin

Insider Network Chart

Rod D Martin Owned Company Details

What does Galectin Therapeutics Inc do?

Who are the key executives at Galectin Therapeutics Inc?

Rod D Martin is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .

Galectin Therapeutics Inc (GALT) Insider Trades Summary

Over the past 18 months, Rod D Martin made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 16,300 shares made by Kevin D Freeman , and a net purchase of 4,500 shares made by Zordani Richard A. Jr. .

In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 15,300 shares, with a net purchase of 15,300 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 25,198 shares were bought by its insiders, resulting in a net purchase of 198 shares.

Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Galectin Therapeutics Inc Insider Transactions

No Available Data

Rod D Martin Mailing Address

Above is the net worth, insider trading, and ownership report for Rod D Martin. You might contact Rod D Martin via mailing address: 7 Wells Avenue, Newton Ma 02459.